The plasma level of IL-6, considered as a significant cytokine contributing to MAS, increases both in mild and severe patient groups of COVID-19: severe patients have a significantly higher level of IL-6 than mild or nonsevere patients [6,37,38,40]. Here, IL6 is linked to macrophage activation syndrome.